期刊档案 · 生物-细胞生物学

Current Opinion in Cell Biology

ISSN 0955-0674 · eISSN 1879-0410 · Elsevier Ltd · ENGLAND · Bimonthly · 创刊 1989

Current Opinion in Cell Biology 中科院 生物学 2区(2025 年升级版),影响因子 6.16,混合开放获取,APC 约 4,390 美元,近 24 个月 96 篇文章投稿到接收中位 99 天,录用比例很难(社区反馈),2025 年发文 125 篇,SCIE、Scopus 收录。

影响因子6.16LetPub 汇总的最新公布值
中科院分区生物学 2区2025 年升级版大类 · 2026 新锐版 生物学 2区
审稿周期99 天投稿到接收中位数 · 近 24 个月 96 篇文章 · PubMed
版面费4,390 USD混合期刊,仅开放获取发表时收取
录用比例很难投稿社区平均反馈
年发文量125 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Current Opinion in Cell Biology 由 Elsevier Ltd 出版,属中科院生物学大类(2025 升级版2区)。按 OpenAlex 近年发文统计,该刊主要发表 Microtubule and mitosis dynamics、Cellular Mechanics and Interactions、Cellular transport and secretion 等主题的论文,这 3 个主题约占 26.2%,主导子领域为 Molecular Biology、Cell Biology。(根据 OpenAlex 主题统计与中科院分区数据生成)

Current Opinion in Cell Biology (COCEBI) publishes authoritative, comprehensive, and systematic reviews. COCEBI helps specialists keep up to date with a clear and readable synthesis on current advances cell biology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.Current Opinion in Cell Biology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. The subject of cell biology is divided into six themed sections, each of which is reviewed once a year. Themes include cell architecture; cell signaling; cell nucleus; membrane trafficking; cell dynamics; and stem cells.The journal builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.Expertise – Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.Comprehensiveness – There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry.Impact – In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores.Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. Reviews Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the auth

摘自期刊官网 Aims & Scope

研究方向(LetPub):生物-细胞生物学

主编 Anne Ridley出版商官网

编委会国家分布:中国大陆 1 位(约 2%);主要国家 美国 21、日本 8、德国 8、英国 3、法国 2(共 59 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Microtubule and mitosis dynamicsBiochemistry, Genetics and Molecular Biology8.9%
  2. Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology8.9%
  3. Cellular transport and secretionBiochemistry, Genetics and Molecular Biology8.4%
  4. RNA Research and SplicingBiochemistry, Genetics and Molecular Biology7.3%
  5. Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology6.8%
  6. Cell Adhesion Molecules ResearchMedicine5.3%
  7. Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.4%
  8. Human auditory perception and evaluationEngineering4.3%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)生物学 2 区
类别学科分区
大类生物学2 区
小类细胞生物学CELL BIOLOGY3 区

Top 期刊:否综述期刊:是

《新锐期刊分区表》( 2026年3月发布)生物学 2 区
类别学科分区
大类生物学2 区
小类细胞生物学CELL BIOLOGY3 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)生物学 2 区
类别学科分区
大类生物学2 区
小类细胞生物学CELL BIOLOGY2 区

Top 期刊:否综述期刊:是

数据库收录

SCIEScopusLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子
6.16LetPub ·
影响因子(出版商公布)
6.2出版商官网 ·
CiteScore 2026-06
8LetPub ·
CiteScore(出版商公布)
8出版商官网 ·
SJR 2026-06
2.85LetPub ·
SNIP 2026-06
1.36LetPub ·
h-index
242LetPub ·
h-index
336OpenAlex ·
i10-index
3,416OpenAlex ·
两年平均被引
7.09OpenAlex ·
自引率
3.2%LetPub ·
Gold OA 文章占比
58.25%LetPub ·

发文规模

年文章数
98LetPub ·

逐年发文量 OpenAlex 统计 · 累计 4,633 篇 · 当年数据不完整

年份发文量其中 OA被引
2026643924
202512597721
2024122951,460
2023123842,160
202281461,737
202193613,759

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

99 天投稿到接收中位数 · P25–P75 80 天 – 135 天

接收到上线
中位数 26 天(96 篇)
投稿到上线
中位数 125 天
样本
96 篇有投稿与接收日期的文章(窗口内共 176 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
偏慢,4-8周LetPub ·
平均录用比例(社区反馈)
很难LetPub ·
投稿到首次决定
10 天出版商官网 ·
外审后首次决定
58 天出版商官网 ·
投稿到接收
96 天出版商官网 ·
接收到发表
26 天出版商官网 ·
评审方式
单盲同行评审出版商官网

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

混合开放获取LetPub

订阅期刊,作者可付费选择开放获取发表。

来源文章处理费费用减免许可证观测时间
OpenAlexUSD 4,390 / EUR 4,110 / GBP 3,510 / JPY 544,490——
出版商官网USD 4,220——

混合期刊的文章处理费仅在作者选择开放获取发表时收取;按订阅方式发表通常不收费。

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点2 项,摘自作者指南
摘要
≤ 250 词
正文篇幅
≤ 2,000 词
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型2 种,含篇幅限制
  1. opinionKey requirements for authors to take into account when preparing a Current Opinion paper:2000 word limit (excluding abstract, references and figure captions) ex…正文 ≤ 2,000 词
  2. reviewKey requirements for authors to take into account when preparing a Current Opinion paper:2000 word limit (excluding abstract, references and figure captions) ex…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
AI 使用 Declaration of generative AI use

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Group authorship

团体署名指将文章归属于一个明确且具名的作者群体,须在投稿时于标题页声明,并在投稿系统中以"Collaborative Author Groups"填写。 模型中文摘要

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

所有作者必须披露可能不当影响或偏倚其工作的财务和个人关系,并始终完成声明工具。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

原文 ↗出版商官网 ·
许可与版权 License options

作者将获得开放获取用户许可选项,建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

原文 ↗出版商官网 ·
开放获取 Open access

期刊引导作者查阅其开放获取信息页面以了解该期刊的开放获取选项。 模型中文摘要

We refer you to our open access information page to learn about open access options for this journal.

原文 ↗出版商官网 ·
同行评审 Peer review

该期刊采用单盲同行评审,稿件先由编辑评估,通常至少送一位审稿人评审,录用或拒稿决定由编辑作出。 模型中文摘要

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…

原文 ↗出版商官网 ·
预印本 Preprints

作者可按Elsevier文章共享政策分享预印本,分享预印本不计作先前发表。 模型中文摘要

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Elsevier Ltd
出版国家或地区
ENGLAND
出版语言
English
出版周期
Bimonthly
创刊年份
1989
ISSN
0955-0674
电子版 ISSN
1879-0410
官方链接

常见问题

关于 Current Opinion in Cell Biology 的常见问题

Current Opinion in Cell Biology 是中科院几区期刊?

2025 年升级版分区表中,Current Opinion in Cell Biology 为生物学 2区,小类 细胞生物学 3 区。2026 年新锐版分区表中为生物学 2区。不同版本与大小类分区不能混用。

Current Opinion in Cell Biology 的影响因子是多少?

LetPub 汇总的最新公布影响因子为 6.16,CiteScore 为 8,h-index 为 336。

Current Opinion in Cell Biology 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)96 篇已发表文章登记的日期,投稿到接收的中位数为 99 天(四分位 80–135 天);投稿社区反馈的平均审稿速度为4–8 周,平均录用比例反馈为“很难”。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Current Opinion in Cell Biology 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 250 词;正文篇幅:≤ 2,000 词。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Current Opinion in Cell Biology 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 59 位编委中,中国大陆 1 位(约 2%);人数最多的国家是 美国(21 位)、日本(8 位)、德国(8 位)。统计按编委会页面列出的机构国家计,仅供参考。

Current Opinion in Cell Biology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Current Opinion in Cell Biology 被 SCIE、Scopus 收录。

Current Opinion in Cell Biology 是开放获取期刊吗?版面费多少?

Current Opinion in Cell Biology 为混合开放获取。选择开放获取发表时APC 约 4,390 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。